Published in Crit Rev Clin Lab Sci on August 03, 2012
Beyond immunohaematology: the role of the ABO blood group in human diseases. Blood Transfus (2013) 1.18
The intriguing relationship between the ABO blood group, cardiovascular disease, and cancer. BMC Med (2015) 0.97
Blood group distribution and life-expectancy: a single-centre experience. Blood Transfus (2014) 0.88
Acute coronary syndrome: many doubts, some answers. Ann Transl Med (2016) 0.88
The prognostic value of ABO blood group in cancer patients. Blood Transfus (2015) 0.87
Relationship between ABO blood group and pregnancy complications: a systematic literature analysis. Blood Transfus (2016) 0.86
More or less living according to your blood type. Blood Transfus (2014) 0.75
The relationship between ABO blood group and cardiovascular disease: results from the Cardiorisk program. Ann Transl Med (2016) 0.75
Associations between ABO blood groups and biochemical recurrence after radical prostatectomy. Int J Clin Exp Med (2015) 0.75
ABO blood group and neurodegenerative disorders: more than a casual association. Blood Transfus (2015) 0.75
Thrombin Generating Capacity and Phenotypic Association in ABO Blood Groups. PLoS One (2015) 0.75
Blood type biochemistry and human disease. Wiley Interdiscip Rev Syst Biol Med (2016) 0.75
ABO blood group is a predictor of survival in patients with laryngeal cancer. Chin J Cancer (2016) 0.75
Association of ABO blood groups with von Willebrand factor, factor VIII and ADAMTS-13 in patients with lung cancer. Oncol Lett (2017) 0.75
O Blood Group as a Risk Factor for Helicobacter Pylori IgG Seropositivity Among Pregnant Sudanese Women. Clin Pract (2017) 0.75
Influence of ABO blood group on sports performance. Ann Transl Med (2017) 0.75
Do clinicians decide relying primarily on Bayesians principles or on Gestalt perception? Some pearls and pitfalls of Gestalt perception in medicine. Intern Emerg Med (2014) 3.93
Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med (2009) 3.84
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol (2013) 2.92
Acquired factor VIII inhibitors. Blood (2008) 2.67
HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabetes Care (2002) 2.38
25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis (2008) 2.36
Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 Randomized Trial). Hepatology (2013) 2.28
Biochemical markers of muscular damage. Clin Chem Lab Med (2010) 2.25
NASH predicts plasma inflammatory biomarkers independently of visceral fat in men. Obesity (Silver Spring) (2008) 2.23
Rhabdomyolysis: historical background, clinical, diagnostic and therapeutic features. Clin Chem Lab Med (2010) 2.20
Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabetes Care (2007) 2.09
Circulating microRNAs (miRs) for diagnosing acute myocardial infarction: meta-analysis of available studies. Int J Cardiol (2012) 2.07
N-terminal pro-BNP in sclerodermic patients on bosentan therapy for PAH. Rheumatol Int (2007) 2.03
Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. Diabetes Care (2006) 1.92
Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. J Hepatol (2009) 1.72
The order of draw: myth or science? Clin Chem Lab Med (2013) 1.66
The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful? Clin Chem Lab Med (2011) 1.65
Opinion paper on innovative approach of biomarkers for infectious diseases and sepsis management in the emergency department. Clin Chem Lab Med (2013) 1.63
Red blood cell distribution width is significantly associated with aging and gender. Clin Chem Lab Med (2014) 1.58
Preanalytical phase--a continuous challenge for laboratory professionals. Biochem Med (Zagreb) (2012) 1.56
Development of a novel, hemolysis-resistant reagent for assessment of α-amylase in biological fluids. Clin Chem Lab Med (2013) 1.54
Laboratory medicine does matter in science (and medicine)… yet many seem to ignore it. Clin Chem Lab Med (2015) 1.53
Biomedical research platforms and their influence on article submissions and journal rankings: an update. Biochem Med (Zagreb) (2012) 1.53
Relationship between abnormal microvolt T-wave alternans and poor glycemic control in type 2 diabetic patients. Pacing Clin Electrophysiol (2007) 1.52
Prevalence of subclinical hypothyroidism in patients with chronic kidney disease. Clin J Am Soc Nephrol (2008) 1.50
Postoperative variation of C-reactive protein and procalcitonin in patients with gastrointestinal cancer. Clin Lab (2009) 1.49
Associations between liver histology and early carotid atherosclerosis in subjects with nonalcoholic fatty liver disease. Hepatology (2005) 1.48
Acquired factor V inhibitors: a systematic review. J Thromb Thrombolysis (2011) 1.47
Effects of moderate-intensity exercise training on plasma biomarkers of inflammation and endothelial dysfunction in older patients with type 2 diabetes. Nutr Metab Cardiovasc Dis (2006) 1.45
Should women with abnormal serum thyroid stimulating hormone undergo screening for anemia? Arch Pathol Lab Med (2008) 1.45
Together we care: new challenges for global haemophilia treatment centers. Indian J Med Res (2009) 1.44
Red blood cell distribution width: A simple parameter with multiple clinical applications. Crit Rev Clin Lab Sci (2014) 1.44
New ways to deal with known preanalytical issues: use of transilluminator instead of tourniquet for easing vein access and eliminating stasis on clinical biochemistry. Biochem Med (Zagreb) (2011) 1.43
2B or not 2B? Differential identification of type 2B, versus pseudo-von Willebrand disease. Br J Haematol (2006) 1.43
Differential identification of a rare form of platelet-type (pseudo-) von Willebrand disease (VWD) from Type 2B VWD using a simplified ristocetin-induced-platelet-agglutination mixing assay and confirmed by genetic analysis. Br J Haematol (2007) 1.43
Iron and thrombosis. Ann Hematol (2007) 1.43
The V433M variant of the CYP4F2 is associated with ischemic stroke in male Swedes beyond its effect on blood pressure. Hypertension (2008) 1.42
The role of red blood cell distribution width in cardiovascular and thrombotic disorders. Clin Chem Lab Med (2011) 1.42
The baseline serum value of α-amylase is a significant predictor of distance running performance. Clin Chem Lab Med (2015) 1.42
Reliability of the thrombin-generation assay in frozen-thawed platelet-rich plasma. Clin Chem (2006) 1.40
The health risks of acute exercise should also matter to internal medicine. Eur J Intern Med (2011) 1.40
Is laboratory medicine a dying profession? Blessed are those who have not seen and yet have believed. Clin Biochem (2010) 1.40
Reduction of unsuitable specimens: a more radical and comprehensive approach is needed. Clin Chim Acta (2010) 1.39
Preanalytical quality improvement. In pursuit of harmony, on behalf of European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working group for Preanalytical Phase (WG-PRE). Clin Chem Lab Med (2015) 1.39
Mental depression and cardiovascular disease: a multifaceted, bidirectional association. Semin Thromb Hemost (2009) 1.39
The growing impact of publications in haemostasis and thrombosis journals. Thromb Haemost (2007) 1.38
The paradoxical relationship between serum uric acid and cardiovascular disease. Clin Chim Acta (2008) 1.33
Irisin: a new potential hormonal target for the treatment of obesity and type 2 diabetes. J Diabetes (2012) 1.31
Disorders of hemostasis associated with chronic kidney disease. Semin Thromb Hemost (2010) 1.31
Survey of national guidelines, education and training on phlebotomy in 28 European countries: an original report by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) working group for the preanalytical phase (WG-PA). Clin Chem Lab Med (2013) 1.31
Quality standards for sample collection in coagulation testing. Semin Thromb Hemost (2012) 1.29
Vitamin D, thrombosis, and hemostasis: more than skin deep. Semin Thromb Hemost (2012) 1.28
Prothrombin complex concentrates: an update. Blood Transfus (2010) 1.27
Relationship between red blood cell distribution width and kidney function tests in a large cohort of unselected outpatients. Scand J Clin Lab Invest (2008) 1.25
The role of ethnicity, age and gender in venous thromboembolism. J Thromb Thrombolysis (2010) 1.24
Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function. Diabetes Care (2011) 1.23
Uric acid as a target of therapy in CKD. Am J Kidney Dis (2012) 1.22
Biological variation and reference change values: an essential piece of the puzzle of laboratory testing. Clin Chem Lab Med (2012) 1.22
The utility of serum human epididymis protein 4 (HE4) in patients with a pelvic mass. J Clin Lab Anal (2009) 1.20
Mean platelet volume increases with aging in a large population study. Thromb Res (2012) 1.20
Impact of the phlebotomy training based on CLSI/NCCLS H03-a6 - procedures for the collection of diagnostic blood specimens by venipuncture. Biochem Med (Zagreb) (2012) 1.20
Acquired factor VIII inhibitors in oncohematology: a systematic review. Crit Rev Oncol Hematol (2008) 1.19
Laboratory, clinical and therapeutic aspects of acquired hemophilia A. Clin Chim Acta (2008) 1.19
Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes. Diabetes Care (2011) 1.19
Clinical usefulness of measuring red blood cell distribution width on admission in patients with acute coronary syndromes. Clin Chem Lab Med (2009) 1.19
25-Hydroxyvitamin D deficiency and inflammation and their association with hemoglobin levels in chronic kidney disease. Am J Nephrol (2009) 1.17
Fibrinogen replacement therapy: a critical review of the literature. Blood Transfus (2011) 1.17
The latest generation of troponin immunoassays: the "cholesterol" of the third millennium? J Am Coll Cardiol (2014) 1.16
Arterial thrombus formation in cardiovascular disease. Nat Rev Cardiol (2011) 1.15
Preanalytical management: serum vacuum tubes validation for routine clinical chemistry. Biochem Med (Zagreb) (2012) 1.14
Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis. Clin J Am Soc Nephrol (2010) 1.14
Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications. Thromb J (2007) 1.13
Acquired von Willebrand syndrome: an update. Am J Hematol (2007) 1.13
Association between 25-hydroxyvitamin D deficiency and cardiovascular disease in type 2 diabetic patients with mild kidney dysfunction. Nephrol Dial Transplant (2007) 1.13
Different manufacturers of syringes: a new source of variability in blood gas, acid-base balance and related laboratory test? Clin Biochem (2012) 1.13
Predictors of estimated GFR decline in patients with type 2 diabetes and preserved kidney function. Clin J Am Soc Nephrol (2012) 1.12
Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease. J Am Soc Nephrol (2008) 1.12
Smoking-related mortality in the United States. N Engl J Med (2013) 1.12
Increased mean platelet volume in patients with acute coronary syndromes. Arch Pathol Lab Med (2009) 1.11
Compliance of blood sampling procedures with the CLSI H3-A6 guidelines: An observational study by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) working group for the preanalytical phase (WG-PRE). Clin Chem Lab Med (2015) 1.11
Recent acquisitions in the pathophysiology, diagnosis and treatment of disseminated intravascular coagulation. Thromb J (2006) 1.10
A comparative study on the reliability of an automated system for the evaluation of cell-based indirect immunofluorescence. Autoimmun Rev (2012) 1.10
Other advantages to aerobic exercise. CMAJ (2005) 1.10
Elevated serum uric acid concentrations independently predict cardiovascular mortality in type 2 diabetic patients. Diabetes Care (2009) 1.09
Improving diagnosis and reducing diagnostic errors: the next frontier of laboratory medicine. Clin Chem Lab Med (2016) 1.09
The clinical and economic burden of drawing blood through intravenous catheters. J Emerg Nurs (2013) 1.08
Overview on self-monitoring of blood glucose. Clin Chim Acta (2009) 1.08
Relationship between serum vitamin D and inflammatory markers in the general population: comment on the article by Patel et al. Arthritis Rheum (2008) 1.08
Increased risk of cardiovascular disease and chronic kidney disease in NAFLD. Nat Rev Gastroenterol Hepatol (2012) 1.07
Effect of lovastatin on primary prevention of cardiovascular events in mild CKD and kidney function loss: a post hoc analysis of the Air Force/Texas Coronary Atherosclerosis Prevention Study. Am J Kidney Dis (2009) 1.07
Preanalytic error tracking in a laboratory medicine department: results of a 1-year experience. Clin Chem (2006) 1.07